Device
TECAR
TECAR is a medical device with 3 clinical trials. Historical success rate of 100.0%.
Total Trials
3
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 3 completed trials
Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Phase Distribution
Ph not_applicable
3
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
100.0%
3 of 3 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
0
trials recruiting
Total Trials
3
all time
Status Distribution
Completed(3)
Detailed Status
Completed3
Development Timeline
Analytics
Development Status
Total Trials
3
Active
0
Success Rate
100.0%
Most Advanced
N/A
Trials by Phase
N/A3 (100.0%)
Trials by Status
completed3100%
Recent Activity
0 active trials
Showing 3 of 3
completednot_applicable
Effectiveness Transfer Energy Capacitive and Resistive Therapy in Patients With Carpal Tunnel Syndrome
NCT06451094
completednot_applicable
Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
NCT06418360
completednot_applicable
Comparison the Effects of TECAR With Dry Needling in the Treatment of Myofascial Trigger Points
NCT06273514
Clinical Trials (3)
Showing 3 of 3 trials
NCT06451094Not Applicable
Effectiveness Transfer Energy Capacitive and Resistive Therapy in Patients With Carpal Tunnel Syndrome
NCT06418360Not Applicable
Efficacy of TECAR Therapy in Patients With Knee Osteoarthritis
NCT06273514Not Applicable
Comparison the Effects of TECAR With Dry Needling in the Treatment of Myofascial Trigger Points
All 3 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 3